Analyst Price Targets — DVA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 7, 2026 2:08 pm | — | Truist Financial | $215.00 | $179.93 | TheFly | DaVita price target lowered to $215 from $250 at Truist |
| August 7, 2026 9:31 am | — | Raymond James | $220.00 | $180.67 | StreetInsider | TD Cowen Upgrades DaVita (DVA) to Buy |
| August 7, 2026 9:31 am | — | Oppenheimer | $220.00 | $180.67 | StreetInsider | TD Cowen Upgrades DaVita (DVA) to Buy |
| August 5, 2026 1:18 pm | Pito Chickering | Deutsche Bank | $265.00 | $185.53 | TheFly | DaVita price target raised to $265 from $220 at Deutsche Bank |
| August 5, 2026 9:08 am | Andrew Mok | Barclays | $224.00 | $227.99 | TheFly | DaVita price target raised to $224 from $218 at Barclays |
| July 14, 2026 11:49 am | — | Truist Financial | $250.00 | $235.58 | TheFly | DaVita price target raised to $250 from $205 at Truist |
| July 10, 2026 10:17 am | — | UBS | $270.00 | $229.48 | TheFly | DaVita price target raised to $270 from $235 at UBS |
| July 8, 2026 10:20 am | — | Barclays | $218.00 | $234.31 | TheFly | DaVita price target raised to $218 from $194 at Barclays |
| May 8, 2026 11:56 am | — | Truist Financial | $205.00 | $194.39 | TheFly | DaVita price target raised to $205 from $158 at Truist |
| May 7, 2026 9:46 am | Andrew Mok | Barclays | $194.00 | $193.88 | TheFly | DaVita price target raised to $194 from $158 at Barclays |
Latest News for DVA
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
In fact, it's a healthcare company. It is a strong player in its chosen niche.
DaVita expands its Humana partnership to earlier-stage kidney disease, bringing value-based care to over 10,000 Medicare Advantage members.
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date of the interim results announcement, the Company made significant…
More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizations DENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to deliver comprehensive, coordinated care to Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5. Launched July 1, this partnership builds on the organizations' long-standing…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.